Search

Your search keyword '"Bonten, M"' showing total 1,089 results

Search Constraints

Start Over You searched for: Author "Bonten, M" Remove constraint Author: "Bonten, M"
1,089 results on '"Bonten, M"'

Search Results

1. Epidemiologie van infectieziekten

2. Perpetual Observational Studies: New strategies to support efficient implementation of observational studies and randomized trials in the infectious diseases arena

5. A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial

7. Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls

9. Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: A test-negative case-control study

10. CHARACTERIZATION OF BACTEREMIC AND NON-BACTEREMIC SYNDROMES OF INVASIVE ESCHERICHIA COLI DISEASE AMONG HOSPITALIZED ADULTS AGED ≥60 YEARS: FINDINGS FROM A PROSPECTIVE, MULTINATIONAL, OBSERVATIONAL STUDY (EXPECT-2)

11. Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study

12. Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers

13. Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial):Protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment

14. EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach

16. Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19

17. Additional file 1 of Dynamics of colistin and tobramycin resistance among Enterobacter cloacae during prolonged use of selective decontamination of the digestive tract

18. Faster clinical recovery with ensovibep compared to placebo in patients with mild-to-moderate COVID-19: interim results from the EMPATHY Phase 2 trial

20. ESICM LIVES 2016: part two: Milan, Italy. 1–5 October 2016

21. Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial

23. Secular Trends in Nosocomial Bloodstream Infections: Antibiotic-Resistant Bacteria Increase the Total Burden of Infection

24. A guide to immunotherapy for COVID-19

32. The European clinical research response to optimise treatment of patients with COVID-19 : lessons learned, future perspective, and recommendations

40. Gram-positive cocci in Dutch ICUs with and without selective decontamination of the oropharyngeal and digestive tract: a retrospective database analysis

41. The Innovative Medicines Initiativeʼs New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistance

42. Molecular epidemiology of MRSA in 13 ICUs from eight European countries

43. Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins

45. ESICM LIVES 2016: part one: Milan, Italy. 1-5 October 2016

46. Survey of metallo-β-lactamase-producing Enterobacteriaceae colonizing patients in European ICUs and rehabilitation units, 2008–11

47. MLST reveals potentially high-risk international clones of Enterobacter cloacae

49. Immunogénicité et tolérance d’un vaccin grippal quadrivalent à haute dose par rapport à un vaccin grippal quadrivalent à dose standard chez des sujets de 60 ans et plus : un essai randomisé de phase III

Catalog

Books, media, physical & digital resources